Who are SodiumChloride's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Potassium Phosphates, Plegisol In Plastic Container, Normal Saline 0.9% Infusion Solution Bag, Chlorure de sodium 0.9%, Saline solution isotonic 0.9% NaCl, Sodium Chloride 0.9% Intravenous Solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodiumchloride.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

SodiumChloride — Competitive Intelligence Brief

SodiumChloride (SodiumChloride) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte replacement. Area: General/Supportive Care.

phase 3 Electrolyte replacement General/Supportive Care Small molecule Live · refreshed every 30 min

Target snapshot

SodiumChloride (SodiumChloride) — Radboud University Medical Center. Sodium chloride replaces electrolytes and restores osmotic balance in body fluids.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
SodiumChloride TARGET	SodiumChloride	Radboud University Medical Center	phase 3	Electrolyte replacement
Potassium Phosphates	Potassium Phosphate, Dibasic	Pfizer	marketed	Electrolyte replacement	Phosphorus homeostasis and cellular biochemical functions	1993-01-01
Plegisol In Plastic Container	Calcium Chloride	Pfizer	marketed	Electrolyte replacement solution	Electrolyte balance and fluid homeostasis	1971-01-01
Normal Saline 0.9% Infusion Solution Bag	Normal Saline 0.9% Infusion Solution Bag	Vanderbilt University Medical Center	marketed	Crystalloid fluid / Electrolyte replacement solution
Chlorure de sodium 0.9%	Chlorure de sodium 0.9%	Centre Hospitalier Universitaire Dijon	marketed	Electrolyte replacement solution
Saline solution isotonic 0.9% NaCl	Saline solution isotonic 0.9% NaCl	Krankenhaus Barmherzige Schwestern Linz	marketed	Crystalloid fluid / Electrolyte replacement solution
Sodium Chloride 0.9% Intravenous Solution	Sodium Chloride 0.9% Intravenous Solution	Department of Medical Services Ministry of Public Health of Thailand	marketed	Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte replacement class)

Pfizer · 1 drug in this class
Radboud University Medical Center · 1 drug in this class
University Hospital, Limoges · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SodiumChloride — Competitive Intelligence Brief. https://druglandscape.com/ci/sodiumchloride. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab